Superficial oral fungal infections.

Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Superficial oral fungal infections.

Curr Opin Dent. 1991 Aug;1(4):415-22. Unique Identifier : AIDSLINE MED/92199203
Samaranayake LP; University of Hong Kong.

Abstract: Fungal infections in humans are provoked and exacerbated by defects in the cellular immune system. Hence, the emergence of novel clinical variants of oral candidoses and rare mycoses with the pandemic spread of human immunodeficiency virus infection is not surprising. The new clinical entities of oral candidoses that have been described in the past few years have had a significant impact on the classification of these diseases. Classification of oral candidoses is an issue addressed in some detail here. Angular cheilitis is a disease commonly associated with Candida infection. In the West, it is frequently seen in the elderly, but a report from Asia indicates that the disease may be prevalent in the young age groups due to factors such as anemia, despite the similarity of the infective agents. A novel cofactor implicated in infectious states has been the host blood group secretor status, and data from three studies suggest that the latter may play an intriguing role in the pathogenesis of oral candidosis. Finally, a new mouse model has been described as a substitute for the rat model in investigating the host-parasite interactions in oral candidosis, and its pros and cons are reviewed.

Keywords: Acquired Immunodeficiency Syndrome/*COMPLICATIONS Aged Animal Antifungal Agents/THERAPEUTIC USE Aspergillosis/COMPLICATIONS Candidiasis, Oral/CLASSIFICATION/*COMPLICATIONS/DRUG THERAPY Histoplasmosis/COMPLICATIONS Human HIV Infections/*COMPLICATIONS Lichen Planus/MICROBIOLOGY Mice Mouth Diseases/*COMPLICATIONS Mycoses/*COMPLICATIONS JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL
920730
M9271069

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .